Thermo Fisher Scientific (TMO) Share-based Compensation (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Share-based Compensation for 18 consecutive years, with $82.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation rose 1.23% year-over-year to $82.0 million; the trailing twelve-month figure through Jun 2026 stood at $319.0 million (up 5.28% YoY), and the FY2025 full-year result was $310.0 million, up 2.99% from the prior year.
• Share-based Compensation fell to $82.0 million in Q2 2026 per TMO's latest filing, from $83.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $84.0 million in Q2 2024 and bottomed at $61.0 million in Q4 2023.
• Historically, Share-based Compensation has averaged $75.6 million across 5 years, with a median of $76.5 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation soared 52.94% in 2022, then slipped 18.67% in 2023.
• Over 5 years, Share-based Compensation stood at $75.0 million in 2022, then retreated by 18.67% to $61.0 million in 2023, then rose by 29.51% to $79.0 million in 2024, then gained by 6.33% to $84.0 million in 2025, then retreated by 2.38% to $82.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $82.0 million, $83.0 million, and $84.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.